Delaware Healthcare I
Delaware Group Equity Funds IV One Commerce Square,2005 Market Street Philadelphia, P
Map
Phone: 800-362-7500
| Category: | Health | | Fund Family: | Delaware Investments | | Net Assets: | 2.88M | | Year-to-Date Return: | 0.20% | | Yield: | 0.20% | | Morningstar Rating: | N/A | | Fund Inception Date: | 28-Sep-07 |
|
Liu-Er Chen
Lead Manager since
28-Sep-07 | | | Chen is a senior vice president with Delaware Investments , his employer since September 2006 . Previously, he spent nearly 11 years at Evergreen Investment Management Company and three years in U.S. and Germany pharmaceutical companies in their strategic planning area. Chen holds the Chartered Financial Analyst designation. |
| Min Initial Investment: | $0 | | Min Initial Investment, IRA: | NaN | | Min Initial Investment, AIP: | NaN | | Min Subsequent Investment: | $0 | | Min Subsequent Investment, IRA: | N/A | | Min Subsequent Investment, AIP: | N/A |
|
| |
| The investment seeks maximum long-term capital growth capital appreciation. The fund normally invests at least 80% of assets in the equity securities of health care companies. It invests in U.S. and non-U.S. companies across all market capitalizations. The fund may also invest in companies located in emerging markets. It is nondiversified. |
| Last Dividend
(7-Dec-09):
| 0.02 | | Last Cap Gain
(7-Dec-09):
| 1.28 | | Annual Holdings Turnover
| 240.00% | | Average for Category:
| 152.72% |
|
| Expense | DLHIX | Category
Avg | | Total Expense Ratio: | 1.35%
| 1.91% | | Max 12b1 Fee: | %
| N/A | | Max Front End Sales Load: | %
| 5.33% | | Max Deferred Sales Load: | %
| 2.90% | | 3 Yr Expense Projection*: |
$ 1,059 | $763 | | 5 Yr Expense Projection*: |
$ 1,793 | $1,175 | | 10 Yr Expense Projection*: |
$ 3,730 | $2,275 |
|
|
1.52% Nasdaq 
Profile
